MacroGenics Provides Update on Corporate Progress and Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Macrogenics (MGNX) Tops Q3 EPS by 27c, Revenues Beat
November 4, 2020 5:50 PM ESTMacrogenics (NASDAQ: MGNX) reported Q3 EPS of ($0.66), $0.27 better than the analyst estimate of ($0.93). Revenue for the quarter came in at $18.25 million versus the consensus estimate of $15.79 million.
MacroGenics continued the advancement of its portfolio of multiple clinical... More
